 Image via Wikipedia |
The Department of Health and Human Services (HHS) is proposing to treat Chronic Lymphocytic Leukemia (CLL) as a radiogenic cancer under EEOICPA. Under the current final rule on Guidelines for Determining the Probability of Causation Under EEOICPA (42 CFR Part 81) published in 2002, all types of cancers, except for CLL, are treated as being potentially caused by radiation and therefore, as potentially compensable under EEOICPA. HHS proposes to reverse its decision to exclude CLL from such treatment.
(March 21, 2011)
PDF 270 KB (8 pages)HHS invites written comments on this Notice of Proposed Rulemaking from interested parties. Comments must be received by June 20, 2011.
Persons or organizations interested in participating in this rulemaking by submitting written views, arguments, recommendations, and data can submit comments by e-mail or mail. Comments should be addressed to the NIOSH Docket Officer, titled "NIOSH Docket #209," and should identify the author(s), return address, and a phone number, in case clarification is needed.
- E-mail: NIOSH Docket Officer, nioshdocket@cdc.gov. Include "NIOSH Docket #209" and "42 CFR 81.30" in the subject line of the message.
- Mail: NIOSH Docket Office,Robert Taft Laboratories, MS-C344676 Columbia Parkway, Cincinnati, OH 45226
All communications received on or before the closing date for comments will be fully considered by HHS.
All comments submitted will be available for examination in the rule docket (a publicly available storage of the documents associated with the rulemaking) both before and after the closing date for comments.
A complete electronic docket containing all comments submitted will be available athttp://www.cdc.gov/niosh/docket/archive/docket209.html or comments will be available in hard-copy by request.
For over 3 decades the Law Offices of Jon L. Gelman 1.973.696.7900 jon@gelmans.com have been representing injured workers and their families who have suffered work related accidents and injuries.
